4.7 Review

Epigenomic drivers of immune dysfunction in aging

期刊

AGING CELL
卷 18, 期 1, 页码 -

出版社

WILEY
DOI: 10.1111/acel.12878

关键词

chromatin; epigenetics; histone modifications; immune aging; immunity; progeria

资金

  1. National Health and Medical Research Council (NHMRC) of Australia
  2. NHMRC Early Career Fellowship [1125436]
  3. Australian Research Council Future Fellowship [130100541]
  4. National Health and Medical Research Council of Australia [1125436] Funding Source: NHMRC

向作者/读者索取更多资源

Aging inevitably leads to reduced immune function, leaving the elderly more susceptible to infections, less able to respond to pathogen challenges, and less responsive to preventative vaccinations. No cell type is exempt from the ravages of age, and extensive studies have found age-related alterations in the frequencies and functions of both stem and progenitor cells, as well as effector cells of both the innate and adaptive immune systems. The intrinsic functional reduction in immune competence is also associated with low-grade chronic inflammation, termed inflamm-aging, which further perpetuates immune dysfunction. While many of these age-related cellular changes are well characterized, understanding the molecular changes that underpin the functional decline has proven more difficult. Changes in chromatin are increasingly appreciated as a causative mechanism of cellular and organismal aging across species. These changes include increased genomic instability through loss of heterochromatin and increased DNA damage, telomere attrition, and epigenetic alterations. In this review, we discuss the connections between chromatin, immunocompetence, and the loss of function associated with mammalian immune aging. Through understanding the molecular events which underpin the phenotypic changes observed in the aged immune system, it is hoped that the aged immune system can be restored to provide youthful immunity once more.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据